C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) A61K 31/70 (2006.01) A61K 39/015 (2006.01) A61K 48/00 (2006.01) C07K 14/445 (2006.01) C07K 19/00 (2006.01) C12N 15/30 (2006.01) C12N 15/86 (2006.01)
Patent
CA 2245002
The present invention relates to a malaria chimeric peptide comprising a vaccinia virus system which expresses a protein corresponding substantially to the major merozoite surface antigen 1 (MSA1) of <u>Plasmodium</u> <u>flaciparum</u> or an immunogenic portion, thereof. In preferred embodiments, the MSA1 peptide is a 593 amino acid peptide corresponding to amino acids 1047 to 1640 of MSA1 and is combined with a signal peptide and/or an anchor peptide. Chimeric peptides having both signal and anchor sequences in combination with MSA1 sequences were the most effective in eliciting an immunogenic response from a vaccinated host.
L'invention concerne un peptide chimère de la malaria, constitué d'un système vaccinal viral qui exprime une protéine correspondant sensiblement à l'antigène majeur 1 de surface de mérozoïte (MSA1) de <u>Plasmodium</u> <u>falciparum</u> ou à une portion immunogène de celui-ci. Dans des formes d'exécution préférées, le peptide de MSA1 est un peptide à 593 aminoacides correspondant aux aminoacides 1047 à 1640 de MSA1 et il est combiné à un peptide signal et/ou à un signal d'ancrage. Les peptides chimères, ayant simultanément des séquences signal et d'ancrage associées à des séquences de MSA1, étaient particulièrement efficaces pour provoquer une réponse immune chez un hôte vacciné.
Davidson Eugene A.
Yang Shutong
Cassan Maclean
Georgetown University
LandOfFree
Malaria vaccine based upon the addition of a msa1 peptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Malaria vaccine based upon the addition of a msa1 peptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Malaria vaccine based upon the addition of a msa1 peptide will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1793485